British Thoracic Society runs NHS England's MDR-TB Clinical Advice Service
- NHS England
- London
- Below threshold - without competition
- 21 July 2026 to 31 March 2027
NHS England pays the British Thoracic Society to run the MDR-TB Clinical Advice Service, which supports clinicians treating multi-drug resistant TB. The service reviews and signs off requests from local MDR-TB centres to use Bedaquiline and Delamanid. The aim is safe, consistent expert advice.
NHS England awarded the £50,000 contract directly, without competition. Administrative and operational delays meant the award came after the contract's start in April 2026. It runs to March 2027.
Contract ends March 2027
- What
- Acute and specialised hospital services
- Buyer
- NHS England
- Supplier
- British Thoracic Society
- Value
- £50,000
- How it was bought
- Below threshold - without competition
- Dates and next
- Jul 2026 to Mar 2027